ABSTRACT
INTRODUCTION
Salmonella species cause a variety of infections in humans and domestic animals, ranging from mild food poisoning-gastroenteritis, an acute localized inflammation of the intestine caused by Salmonella enterica serovar Typhimurium, to severe systemic lifethreatening illness caused by serovar Typhi and serovar Paratyphi such as enteric fever. During Salmonella infections, the ensuing inflammatory response of the intestinal mucosa is commonly associated with 1, 2 virulence. Infiltrating inflammatory cells participate in the destruction of the invading microbe by the release of certain non enzymatic mediators-oxygen and nitrogen 3 metabolites; enzymatic mediators and cytokines , which attack the polyunsaturated fatty acids in the membrane 4 causing damage to the DNA and proteins. However uncontrolled release of cytotoxic substances and proinflammatory mediators (Tumor necrosis factor and Interleukins) by the migrating cells resulting into oxidative stress, may damage the host tissues as well. Therefore, under such conditions, it is necessary to manage the hyper inflammation level to change the clinical manifestation of the disease. The use of antiinflammatory drugs (antibiotics) is the main strategy for the eradication of this problem, but the increased resistance is an inevitable side effect of the repeated 5, 6 antibiotic use , thus increasing the cost of therapy. Studies have shown the increased prevalence of [7] [8] [9] antibiotic resistant Salmonella in humans and animals has resulted into chronic toxicity besides disrupting the 10 normal flora of the host . These shortcomings lead to an urgent global call for natural antibacterial and antiinflammatory compounds which are biocompatible, safer and are cost effective.
Withania somnifera commonly known as ashwagandha has a high repute in the traditional Indian medicine, and is one of the most extensively used plant in Ayurveda and 11 Unani medicine . It is wide spread in Africa, [12] [13] [14] Mediterranean region and the Middle East.
It has certain antibacterial, anti-hyperglycemic, anti-oxidant and anti-tumor properties to treat ulcers and senile dementia. Most of its biological activities have been attributed to the presence of certain compounds called 15, 16 withanolides . Withania has been demonstrated to possess strong anti-fungal activity and is effective 17, 18 against the treatment of murine aspergillosis . Although a lot of work has been carried out on the medicinal applications of Withania somnifera (stem and [19] [20] [21] leaves) , but the antibacterial and immunomodulatory potential of the root extracts of Withania need to be explored more especially against the treatment of severe life threatening bacterial infections. To the best of our knowledge, although there is only one 22 report on its antibacterial activity against Salmonella , but, the underlying mechanism involved in the modulation currently remains unexplored. Therefore the aim of the present study was to evaluate the strong antibacterial, immuno-modulatory as well as antiinflammatory potential of Withania somnifera against Salmonella enterica serovar Typhimurium as evidenced by in vitro, ex vivo and in vivo studies.
MATERIALS AND METHODS

Ethics statement
The experimental protocols were approved by the 
Animals
Female inbred BALB/c mice, 4-6 weeks old (16-22 gm in weight), were procured from the Central Animal House, Panjab University, Chandigarh (India). Animals were maintained in a well-ventilated room, and were allowed free access to food (Ashirwad Industries Pvt Ltd, Punjab, India) and water ad-libitum.
Bacterial strain and growth conditions
Standard strain of Salmonella enterica serovar Typhimurium NCTC74, originally procured from Central Research Institute, Kasauli, India, was used in the present study. This strain has been maintained in our laboratory for the last several years and has also been 18, 19 used in recent studies. Stock cultures were prepared and stored at -80 °C in glycerol (20%). Purity of the strain was confirmed biochemically as well as serologically.
For preparation of bacterial cell suspension, bacterial cells grown overnight (at 37 °C, 150 rpm) in nutrient broth (5.0 gm/l peptone, 5.0 gm/l NaCl, 1.5 gm/l beef extract, 1.5 gm/l yeast extract, pH 7.4±0.2) were harvested by centrifugation (8000 rpm, 15 minutes), washed once with 10 mM sodium phosphate-buffered saline (PBS, pH 7.2), and resuspended in PBS to a final concentration of approximately 107 CFU/ml.
Preparation of crude herbal extract
Commercially available ashwagandha (Withania somnifera) powder, net weight-60gm, manufactured by Dabur, India Ltd., was used for the study. The powder was suspended in 0.5% carboxymethyl cellulose (CMC, w/v in distilled water) serving as a vehicle and was mixed thoroughly using vortex to give final concentrations of 0.5% to 2%. The powder was stored at room temp in its provided bottle and was kept away from any kind of moisture.
Screening of antibacterial activity by the agar well diffusion method
The anti-Salmonella activity of Withania somnifera was 23 tested using the modified agar well diffusion method. Soft nutrient agar plates seeded with 107 CFU/ml of the Salmonella enterica serovar Typhimurium were prepared. Wells were bored (4mm diameter) in the agar plates with the help of a sterile cork borer and 100µl ashwagandha suspension at different concentrations, ranging from 0.5-2% was dispensed into the wells. The o plates were kept at 4 C for 1 hour to allow the complete o diffusion and finally incubated at 37 C overnight. Antibacterial activity was evaluated by measuring the inhibition (clear) zone diameters. Sterile phosphate buffer saline was used as the negative control.
Antibacterial effect of Withania somnifera in terms of colony forming units
Different flasks containing 20 ml nutrient broth were inoculated with 107 CFU/ml of Salmonella enterica serovar Typhimurium followed by the addition of different volumes of a single concentration of ashwagandha (1% w/v). All flasks were incubated under 0 the shaking conditions at 37 C overnight. After 24 hours, 100 µl of the samples were withdrawn from each flask and spread plated on MacConkey agar plates and observed for enumeration of colony forming units.
Anti-inflammmatory potential of Withania somnifera root extract
The anti-inflammatory potential of Withania somnifera powdered root extract on Salmonella induced inflammation was assessed by hyperalgesic (flicking) response of the mice inflamed paws. To induce oedema, animals were divided into the four different groups (each comprising of three mice) and were injected with 0.1ml of the following preparations in the right food pad: (1) 8 0.1ml of bacterial suspension (10 CFU/ml), (2) 0.05 ml of bacterial cell suspension + 0.05 ml of ashwagandha (1% w/v in 0.5% CMC), (3) 0.1ml of 1% (w/v) of carrageenan (as positive control) and, (4) 0.1 ml normal saline (as negative control). All the mice were checked at regular intervals of 30 min for 3 h for inflammation in the right hind foot pad. After 3h, hyperalgesic response was assessed by the paw immersion test. Animals were marked on both the hind paws (right and left), just beyond the tibiotarasal junction to ensure the mice paw was dipped to the same level in the water bath at (47± 0.5°C) each time. Paw flicking response in terms of time (sec) in each of the above groups of mice was recorded.
Immuno-modulatory effects of Withania somnifera on macrophage functions (ex-vivo studies)
Extraction of peritoneal macrophages
Peritoneal macrophages were collected from normal 24 BALB/c mice as described by us earlier . Cell viability was checked by 0.2% trypan blue staining.
Interaction of macrophages infected with Salmonella enterica serovar Typhimurium in the presence and absence of Withania somnifera :
Macrophages (105cells/ml) were infected with Salmonella enterica serovar Typhimurium (107 CFU/ml) at multiplicity of infection 1:100. Extensively washed macrophages were treated with two different concentrations of Withania somnifera i.e. 2mg/ml and 4mg/ml respectively.
Estimation of lipid peroxidation (LPO):
Quantitative measurement of lipid peroxidation in the culture supernatants of macrophages was performed 25 according to the method of Wills. Absorbance of malondialdehyde thus formed was measured at 532nm. The results were expressed as nanomoles of malondialdehyde (MDA) per milligram of protein, using the molar extinction coefficient of chromophore
(1.56x10 M cm ). The protein content of tissue 26 homogenates was calculated as described previously.
Estimation of superoxide dismutase levels (SOD)
Levels of antioxidant superoxide dismutase (SOD) in the culture supernatants of macrophages were measured 27 according to the method of Kono. Change in absorbance was read at 560 nm for 3 minutes with 30 sec interval. SOD activity was expressed as units of SOD per milligram of protein where one unit of activity is defined as the amount of SOD required to inhibit the rate of reduction of NBT by 50%.
Estimation of antibacterial activity of Withania somnifera against systemic murine salmonellosis (in vivo studies)
Each animal was challenged with a single oral dose of
Efficacy of Withania somnifera against Salmonella
Salmonella enterica serovar Typhimurium (0.1ml of 107CFU/ml). The Withania somnifera root powder was resuspended in water to get the suspension of the crude drug. The suspension was administered orally, once daily for seven consecutive days with a dose of 100mg/kg body weight of the animals, while the control group animals did not receive such treatment and were given normal saline only. On day third, each mouse was challenged with a single dose of Salmonella enterica serovar Typhimurium (0.1 ml of 108CFU/ml). Animals in all the challenged groups were sacrificed on 7th day post-Salmonella challenge, whereas all animals in the non-challenged group were sacrificed on 10th day postsupplementation. The assessment of antimicrobial potential of Withania somnifera was demonstrated on the basis of the following parameters:
Bacterial load in the tissue homogenates
Liver, intestine and spleen of all animals (treated and control mice) were immediately removed after sacrifice, rinsed in isotonic saline solution, and weighed. Ten percent (w/v) of tissue homogenates were prepared in sterile PBS using a Potter Elvehjem homogenizer. Serial 10-fold dilutions of each homogenate were plated on MacConkey agar medium and Bismuth sulfite agar medium (BSA) for enumeration of CFU per organ after incubation at 37 °C for 24 hours.
Histopathological studies
Mice were sacrificed and the intestine, liver and spleen were removed from various groups. These were then fixed in 10% buffered formalin and processed for histological examination. After fixation in formaldehyde, tissues were dehydrated in different grades of alcohol ie-70%, 80%, 90% and absolute alcohol for 30 minutes, 40 minutes and 1 hour respectively. Tissues were then washed in xylene for 1 hour at room temperature. The washings were repeated using fresh xylene. The tissues were dipped in molten paraffin wax and the wax was quickly cooled to prevent crystallization. Thin sections of tissues were cut with a fine razor attached to Spencer microtome and kept in a water bath at 50°C to remove wax. Sections were mounted on separate clean glass microscope slides pretreated for electrostatic adherence. Slides were treated with xylene to remove wax and with alcohol to remove xylene and were then rinsed with water. Slides were further stained in hematoxylin till the time only nuclei get stained and were then rinsed in water. Kept under running water for 2-3 minutes and stained in eosin till sections were bright red and washed in running water till eosin was differentiated. Then slides were blot-dried. After mounting in Distyrene Plasticizer Xylene (DPX), slides were examined under the microscope for histological analysis.
Statistical analysis
Data were expressed as means ± standard deviations for three to five independent experiments. Statistical analysis was done by Student's unpaired t test and oneway analysis of variance (ANOVA), followed by pairwise comparison procedures (Tukey test), using Jandel Sigma Stat statistical software, version 2.0. In all cases, statistical significance was defined as having a P value of <0.05.
RESULT & DISCUSSION
Antibacterial potential of Withania somnifera (ashwagandha)
It is clearly indicated from the agar well diffusion assay that ashwagandha, an indigenous medicinal plant, is inhibitory to the growth of Salmonella enterica serovar Typhimurium as evidenced by the zone of growth inhibition in the range of 3-18 mm diameter around the wells filled with 100 µl of different concentrations of ashwagandha used while no zone of inhibition was observed around the control wells (Figure 1 a & b) . This may be attributed to the presence of important 
Antibacterial effect of Withania somnifera in terms of colony forming units
The bactericidal effect of the purified root extract of Withania somnifera was also evaluated against Salmonella enterica serovar Typhimurium in terms of colony forming units (CFU). After 24 hours of incubation with ashwagandha preparation, a log unit decrease of 4.18 was observed in the colony forming units of Salmonella, thus confirming the anti-Salmonella activity of ashwagandha (Table I) .
Measurement of malondialdehyde (MDA) levels
Significantly increased MDA level was observed in the supernatant of macrophages infected with Salmonella enterica serovar Typhimurium (132.36 ± 14.60 nanomoles/mg protein, p<0.05) as compared to that of uninfected macrophages (control, 99.46 ± 11.90 nanomoles/mg protein) (Figure 2a) . However, when the macrophages were infected with Salmonella enterica serovar Typhimurium in the presence of ashwagandha, a significant decrease in the MDA level was observed (84.61±15.03 nanomoles/mg protein, p<0.05). Therefore, it may be suggested that ashwagandha has the potential to scavenge the free radicals thereby decreasing the extent of cell damage. It has been shown that treatment with the extracts of Withania somnifera significantly reduces the tissue injury leading to the 28 decreased peroxidation
Measurement of SOD levels
Significant decrease in the SOD activity (p<0.01) was observed when macrophages were infected with Salmonella (7.34 ± 1.36 units/mg protein) as compared to that of uninfected macrophages (12.46 ± 2.14 units/mg protein). SOD activity might have been decreased due to the consumption of antioxidants to scavenge the oxidants or free radicals. In addition, the efficacy of the antioxidant defense system may be impaired during inflammation, partly as a result of 29 autooxidation. However, treatment of infected macrophages with the ashwagandha resulted in a significant increase in the SOD activity (13.24 ± 2.7 units/mg protein, p<0.01) (Figure 2b) . It has been shown that active components of Withania like sitoindosides and withaferin-A (glycowithanolides), significantly increased the antioxidant activities of SOD, catalytically scavenging superoxide radicals and thus helps to protect 30 the host tissues from oxidative damage.
Anti-inflammatory potential of Withania somnifera (ashwagandha)
Paw flicking response depicts the flicking response of mice with inflamed paw, indicating thermal hyperalgesia (Figure 3) . The time required for the withdrawal of the paw injected with Salmonella enterica serovar Typhimurium cell suspension was significantly shorter (p<0.001) than that of the control paw injected with normal saline, indicating hyperalgesia. Thermal hyperalgesic response significantly reduced upon treatment with the root extract of Withania somnifera (ashwagandha) as the time required for the withdrawal of mice paw injected with serovar Typhimurium cell suspension in the presence of ashwagandha was significantly longer when compared to the infected group (p<0.001), indicating analgesic effect of ashwagandha. The observed anti-inflammatory activity of ashwagandha might be due to the presence of withanolides as the main component of the extract, giving relief from pain induced by inflammation.
Qualitative assessment of inflammation (paw oedema test)
No inflammation was observed in the hind paw of mice injected with normal saline shown in (Figure 4a ) which served as negative control. Inflammation was found to be maximum in the mice injected with Salmonella ( Figure 4b ) which was at par with that induced by carrageenan (positive control, Figure 4c ). However, ashwagandha preparation significantly reduced oedema induced by Salmonella enterica serovar Typhimurium cell suspension (Figure 4d ).
Bacterial load in liver, intestine and spleen
Supplementation with Withania somnifera significantly (p<0.05) decreased the bacterial load in the tissue homogenates of the challenged groups ( Figure 5 ). The results of the present study clearly demonstrate that such treatment successfully obliterated the severity of infection as evident from the reduction in bacterial load in different vital organs. This activity of Withania somnifera may be attributed to the presence of strong immuno-potentiating compounds present in the root 31, 32 extract.
In fact, the compounds present in the root extract might be successful in activation of the immune components of the host, leading to the observed increase in phagocytosis and intracellular killing by peritoneal macrophages. Therefore, the possibility of macrophage activation by Withania somnifera treatment in conjunction with antibacterial property of the active constituents responsible for eliminating the pathogens may be speculated.
Histological studies
Histological evaluation of small intestine sections did not reveal any morphological alterations in the control From the present study, it may be concluded that Withania somnifera possesses strong antibacterial as well as anti-inflammatory potential against Salmonella enterica serovar Typhimurium as evidenced by in-vitro, ex-vivo and in-vivo tests. Interestingly, the in-vivo studies suggesting the oral administration of aqueous root extracts of this plant successfully obliterated Salmonella infection in Balb/C mice. However, further evaluation of the protective efficacy against clinical isolates of Salmonella could be the next key step to confirm the value added potential of this herb. Finally, this study can serve as the pioneer study to evaluate the strategy of using Withania somnifera in conjunction with other herbs or drugs having direct effect on the pathogen.
Conflicts of interest:
None.
